2020³â ´ëÇѱٰ¨¼ÒÁõÇÐȸ Á¦9Â÷ Çмú´ëȸ : 2020-08-22±³À°ÀÏÀÚ : 2020-08-22
±³À°Àå¼Ò : ¼¿ï ¼¼Á¾´ëÇб³ ´ë¾çAIȦ
±³À°ÁÖÁ¦ :
2020³â ´ëÇѱٰ¨¼ÒÁõÇÐȸ Á¦9Â÷ Çмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇÑ°ñ´ë»çÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѱٰ¨¼ÒÁõÇÐȸ
´ã´çÀÚ : ÇÐȸ»ç¹«±¹
¿¬¶ôó : 02-3473-2230
À̸ÞÀÏ :
bone90@empal.com ±³À°Á¾·ù : ³»°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ÀçÈ°ÀÇÇаú, ÇÙÀÇÇаúÀÇ»çÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈÇÐ, ºÐÀÚ»ý¹°ÇÐ
Âü¼®¿¹»óÀοø : 80¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 09:00~09:20 The role of DXA in Sarcopenia ÀÌ»óÀ±(¼¿ïÀÇ´ë ÀçÈ°ÀÇÇаú)
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 09:20~09:40 Ä¿¹Â´ÏƼ Äɾî¿Í ±Ù°¨¼ÒÁõ ¹Ú±â¼ö(°æ»óÀÇ´ë ¿¹¹æÀÇÇаú)
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 09:40~10:00 AWGS ÃֽŠ°¡À̵å¶óÀÎ Update ±è¹ÌÁö(°æÈñ´ëÇб³)
Åä·Ð 08¿ù 22ÀÏ ´ë¾çAIȦ 10:00~10:10 Discussion ()
ÈÞ½Ä 08¿ù 22ÀÏ ´ë¾çAIȦ 10:10~10:30 Coffee break ()
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 10:30~10:50 Nutritional intervention for sarcopenia ¼ÕÁ¤¹Î(¿ø±¤´ëÇб³ ½ÄÇ°¿µ¾çÇаú)
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 10:50~11:10 Precision nutrition for sarcopenia ¾È¿ëÁÖ(Å׶óÁ¨ ÀÌÅؽº)
Åä·Ð 08¿ù 22ÀÏ ´ë¾çAIȦ 11:10~11:20 Discussion ()
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 11:20~11:40 ±Ù°¨¼ÒÁõÀÇ ÀÓ»óÀû Ç¥ÇöÇü°ú Ä¡·á ±âÀü ¹ß±¼À» À§ÇÑ µ¿¹° ¸ðÇü Á¤Èñ¿ø(¼¿ïÀÇ´ë ³»°ú)
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 11:40~12:00 ¹ÌÅäÄܵ帮¾Æ ±â´ÉÁ¦¾î ±Ù°¨¼ÒÁõ µ¿¹°¸ðµ¨ ÀÌÇö½Â(Ãæ³²ÀÇ´ë ³»ºÐºñ³»°ú)
Åä·Ð 08¿ù 22ÀÏ ´ë¾çAIȦ 12:00~12:10 Discussion ()
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 12:10~12:30 Muscle and Bone interaction (Luncheon symposium) È«³²±â(¿¬¼¼ÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 12:30~13:20 Lunch ()
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 13:20~14:20 ÀÚÀ¯¿¬Á¦ ¹Î¿ë±â(¼º±Õ°üÀÇ´ë ³»ºÐºñ³»°ú)
Åä·Ð 08¿ù 22ÀÏ ´ë¾çAIȦ 14:20~14:40 Discussion ()
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 14:40~15:05 Engineering 3D functional neuromuscular junction: strategies for building in vitro and in vivo models ±èµ¿¼º(Æ÷Ç×°ø´ë ±â°è°øÇаú)
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 15:05~15:30 Follistatin increases muscle mass but impairs bone formation ÀÌÀ±½Ç(¼¿ïÀÇ´ë Ä¡ÀÇÇÐ)
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 15:30~15:55 NAD+ metabolism and Muscle aging: what we know and don ·ùµ¿·Ä(¼º±Õ°üÀÇ´ë)
Åä·Ð 08¿ù 22ÀÏ ´ë¾çAIȦ 15:55~16:20 Discussion ()
ÈÞ½Ä 08¿ù 22ÀÏ ´ë¾çAIȦ 16:20~16:30 Coffee break ()
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 16:30~16:55 Management of Fragility Hip Fractures Combined with Sarcopenia º¯¼ºÀº(Â÷ÀÇ´ë Á¤Çü¿Ü°ú)
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 16:55~17:20 Prevalence and prognosis of osteosarcopenia in fragility hip fracture ÇÏ¿ëÂù(Áß¾ÓÀÇ´ë Á¤Çü¿Ü°ú)
±³À°½Ã°£ 08¿ù 22ÀÏ ´ë¾çAIȦ 17:20~17:45 Minimally invasive assessments of skeletal muscle mass and protein dynamics in clinical sarcopenia research: use of stable isotope tracer technology ±èÀÏ¿µ(°¡ÃµÀÇ´ë)
Åä·Ð 08¿ù 22ÀÏ ´ë¾çAIȦ 17:45~18:00 Discussion ()